US Patent 11787784 Solid forms of an HPK1 inhibitor
Patent 11787784 was granted and assigned to Incyte on October, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 19 Oct, 2023
Golden AI
Edits made to:
Infobox (+47 properties)
Article (+519 characters)
US Patent 11787784 Solid forms of an HPK1 inhibitor
Article
Patent abstract
The present invention relates to salt forms of the hematopoietic progenitor kinase 1 (HPK1) inhibitors N-(2-((2S,4S)-4-Amino-2-(hydroxymethyl)pyrrolidin-1-yl)-5-fluorophenyl)-2-(2-fluoro-6-methoxyphenyl)pyrimidine-4-carboxamide and N-(2-((2S,4S)-4-Amino-2-(hydroxymethyl)pyrrolidin-1-yl)-4-(4-cyanopyridin-3-yl)phenyl)-2-(2-fluoro-6-methoxyphenyl)pyrimidine-4-carboxamide, including methods of preparation thereof, where the compounds are useful in the treatment of HPK1 mediated diseases such as cancer.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
William Frietze
Zhongjiang Jia
Date of Patent
October 17, 2023
Patent Application Number
17358991
Date Filed
June 25, 2021
Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11787784 Solid forms of an HPK1 inhibitor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
